CEVEC: ROKOTE Laboratories licenses CEVEC’s CAP® Ad Technology for vaccine manufacturing Written by Kai Schmitz on 20th September 2022. Posted in Client News. [image_slider_no_space on_click=”prettyphoto” height=”600″ navigation_style=”light” images=”940,950,954,952,953,951″] Previous Next